{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:25:42Z","timestamp":1793831142061,"version":"4.6.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bristol-Myers Squibb-Pfizer alliance","award":["CV185-475"],"award-info":[{"award-number":["CV185-475"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardioembolism in paroxysmal atrial fibrillation (PAF) is a preventable cause of transient ischaemic attack (TIA) or ischaemic stroke; however, due to its transient nature, a short-duration Holter monitor may miss a significant proportion of events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted an open-label randomised controlled trial of cardiac monitoring after a TIA or ischaemic stroke comparing a 14-day ECG monitoring patch (Zio<jats:sup>\u00ae<\/jats:sup> Patch, iRhythm Technologies) with short-duration Holter monitoring for the detection of PAF. The primary outcome was the detection of one or more episodes of ECG-documented PAF lasting at least 30\u00a0s within 90\u00a0days in each of the study arms. A budget impact analysis from the healthcare perspective was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From February 2016 through February 2017, 43 (76.8%) of the 56 patients assigned to the patch-based monitoring group and 47 (78.3%) of the 60 patients assigned to short-duration Holter monitoring group had successful monitor placement with 90\u00a0days of follow-up. Of the 26 protocol failures between the two groups, 23 (88.5%) were due to patient refusal for outpatient short-duration ECG monitor placement, whilst only 1 (3.8%) was due unsuccessful ZioPatch placement. The rate of detection of PAF at 90\u00a0days was 16.3% in the patch-based monitoring group (seven patients) compared to 2.1% in the short-duration Holter monitoring group (1 patient), with an odds ratio of 8.9 (95% CI 1.1\u201376.0; <jats:italic>P<\/jats:italic>\u2009=\u20090.026). An economic model demonstrated that implementation of the Zio Patch service would result in 10.8 more strokes avoided per year compared to current practice with Holter monitoring with an associated yearly saving in direct medical costs of \u00a3113,630, increasing to \u00a3162,491 over 5\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Early, prolonged, patch-based monitoring after an index stroke or TIA is superior to short-duration Holter monitoring in the detection of PAF and likely cost-effective for preventing recurrent strokes.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isrctn.com\">http:\/\/www.isrctn.com<\/jats:ext-link>. Unique identifier: ISRCTN 50253271. Registered 21 January 2016<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-019-0383-8","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T07:03:57Z","timestamp":1564124637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial"],"prefix":"10.1186","volume":"24","clinical-trial-number":[{"clinical-trial-number":"isrctn50253271","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4613-4656","authenticated-orcid":false,"given":"Amit","family":"Kaura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Sztriha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong Kum","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Aeron-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlomiej","family":"Piechowski-Jozwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"key":"383_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","volume":"14","author":"L Li","year":"2015","unstructured":"Li L, Yiin GS, Geraghty OC, Schulz UG, Kuker W, Mehta Z, et al. Oxford Vascular Study. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015;14:903\u201313.","journal-title":"Lancet Neurol."},{"key":"383_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ana.410250410","volume":"25","author":"RL Sacco","year":"1989","unstructured":"Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25:382\u201390.","journal-title":"Ann Neurol"},{"key":"383_CR3","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/01.STR.0000131269.69502.d9","volume":"35","author":"DJ Jabaudon","year":"2004","unstructured":"Jabaudon DJ, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004;35:1647\u201351.","journal-title":"Stroke"},{"key":"383_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1212\/WNL.0000000000000145","volume":"82","author":"A Culebras","year":"2014","unstructured":"Culebras A, Mess\u00e9 SR, Chaturvedi S, Kase CS, Gronseth G. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82:716\u201324.","journal-title":"Neurology."},{"key":"383_CR5","volume-title":"National clinic guideline for stroke","author":"Intercollegiate Stroke Working Party","year":"2016","unstructured":"Party Intercollegiate Stroke Working. National clinic guideline for stroke. 5th ed. London: Royal College of Physicians; 2016.","edition":"5"},{"key":"383_CR6","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/STROKEAHA.112.654954","volume":"43","author":"T Rizos","year":"2012","unstructured":"Rizos T, Guntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012;43:2689\u201394.","journal-title":"Stroke"},{"key":"383_CR7","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation (CRYSTAL AF). N Engl J Med. 2014;370:2478\u201386.","journal-title":"N Engl J Med"},{"key":"383_CR8","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. EMBRACE investigators and coordinators. EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467\u201377.","journal-title":"N Engl J Med"},{"key":"383_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.amjcard.2013.04.017","volume":"112","author":"MP Turakhia","year":"2013","unstructured":"Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013;112:520\u20134.","journal-title":"Am J Cardiol"},{"key":"383_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/pace.12053","volume":"36","author":"MA Rosenberg","year":"2013","unstructured":"Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013;36:328\u201333.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"383_CR11","doi-asserted-by":"publisher","first-page":"95.e11","DOI":"10.1016\/j.amjmed.2013.10.003","volume":"127","author":"PM Barrett","year":"2014","unstructured":"Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(1):95.e11\u20137.","journal-title":"Am J Med"},{"key":"383_CR12","unstructured":"The Information Centre for Health and Social Care. Hospital episode statistics\u2014HESonline. http:\/\/www.hesonline.nhs.uk. Accessed 10 Nov 2018."},{"key":"383_CR13","unstructured":"NHS Improvement. NHS Reference Costs 2016\u20132017. https:\/\/improvement.nhs.uk\/resources\/reference-costs\/. Accessed 10 Nov 2018."},{"issue":"1","key":"383_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/2396987317746516","volume":"3","author":"XM Xu","year":"2018","unstructured":"Xu XM, Vestesson E, Paley L, Desikan A, Wonderling D, Hoffman A, et al. The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke. Eur Stroke J. 2018;3(1):82\u201391.","journal-title":"Eur Stroke J."},{"key":"383_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","volume":"16","author":"R Wachter","year":"2017","unstructured":"Wachter R, Gr\u00f6schel K, Gelbrich G, Hammann GF, Kermer P, Liman J, et al. Find-AF(randomised) Investigators and Coordinators. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol. 2017;16:282\u201390.","journal-title":"Lancet Neurol."},{"key":"383_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/europace\/euu213","volume":"17","author":"L\u00c5 Levin","year":"2015","unstructured":"Levin L\u00c5, Husberg M, Sobocinski PD, Kull VF, Friberg L, Rosenqvist M, et al. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke. Europace. 2015;17:207\u201314.","journal-title":"Europace."},{"key":"383_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1212\/WNL.0000000000002282","volume":"86","author":"VN Thijs","year":"2016","unstructured":"Thijs VN, Brachmann J, Morillo CA, Passman RS, Sanna T, Bernstein RA, et al. Predictors for atrial fibrillation detection after cryptogenic stroke: results from CRYSTAL AF. Neurology. 2016;86:261\u20139.","journal-title":"Neurology."},{"key":"383_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/STROKEAHA.115.008714","volume":"46","author":"DJ Gladstone","year":"2015","unstructured":"Gladstone DJ, Dorian P, Spring M, Panzov V, Mamdani M, Healey JS, et al. EMBRACE Steering Committee and Investigators. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial. Stroke. 2015;46:936\u201341.","journal-title":"Stroke"},{"key":"383_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/STROKEAHA.115.008711","volume":"46","author":"S Yaghi","year":"2015","unstructured":"Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke. 2015;46:1488\u201393.","journal-title":"Stroke"},{"key":"383_CR20","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","volume":"26","author":"R Nieuwlaat","year":"2005","unstructured":"Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, et al. European Heart Survey Investigators. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J. 2005;26:2422\u201334.","journal-title":"Eur Heart J"},{"key":"383_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.hjc.2017.03.001","volume":"58","author":"LJ Motloch","year":"2017","unstructured":"Motloch LJ, Reda S, Larbig R, Wolff A, Motloch KA, Wernly B, et al. Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm. Hellenic J Cardiol. 2017;58:204\u201312.","journal-title":"Hellenic J Cardiol."},{"key":"383_CR22","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/pace.12470","volume":"37","author":"T Tischer","year":"2014","unstructured":"Tischer T, Schneider R, Lauschke J, Nesselmann C, Klemm A, Diedrich D, et al. Prevalence of atrial fibrillation in patients with high CHADS2- and CHA2DS2VASc-scores: anticoagulate or monitor high-risk patients? Pacing Clin Electrophysiol. 2014;37:1651\u20137.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"9","key":"383_CR23","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1161\/STROKEAHA.115.011979","volume":"47","author":"JH Yong","year":"2016","unstructured":"Yong JH, Thavorn K, Hoch JS, Mamdani M, Thorpe KE, Dorian P, et al. Potential cost-effectiveness of ambulatory cardiac rhythm monitoring after cryptogenic stroke. Stroke. 2016;47(9):2380\u20135.","journal-title":"Stroke"},{"issue":"10","key":"383_CR24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/jamacardio.2017.3180","volume":"2","author":"JA Reiffel","year":"2017","unstructured":"Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, et al. REVEAL AF Investigators. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the REVEAL AF study. JAMA Cardiol. 2017;2(10):1120\u20137.","journal-title":"JAMA Cardiol."}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-019-0383-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-019-0383-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-019-0383-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:24:14Z","timestamp":1628616254000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-019-0383-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1186\/s40001-019-0383-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]},"assertion":[{"value":"12 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NRES Committee London approved this study (REC Number: 15\/LO\/1534). Written informed consent was obtained from all subjects before the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JT has received grants from Bristol-Meyers-Squibb; Goldman Sachs, Michael J Fox Foundation for Parkinson\u2019s disease.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}